| Value | ₹6.00 Cr |
|---|---|
| Execution period | Within two months |
| hybrid wind-solar capacity | 5.0 MW |
NSE filing, NSE: CHAMBLFERT. Summary written from the filing by ALFA Finder's alert engine.
Chambal Fertilisers & Chemicals Ltd: key numbers
- Share price
- ₹365.70
- Market cap
- ₹14,652 Cr
- Revenue (annual)
- ₹20,794 Cr
- Net profit (annual)
- ₹1,953 Cr
- P/E (TTM)
- 7.6×Sector 9.7×
- Promoter holding
- 61.72%+0.38% QoQ
- FII holding
- 13.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chambal Fertilisers & Chemicals Ltd
All →Chambal Fertilisers & Chemicals Board Meeting Date
Chambal Fertilisers will hold a board meeting on November 3, 2026, to approve quarterly financial results and consider an interim dividend.
Chambal Fertilisers & Chemicals Other Announcement
Chambal Fertilisers and Chemicals Limited filed its quarterly Regulation 74(5) certificate for dematerialization compliance, as mandated by SEBI regulations.
Chambal Fertilisers & Chemicals Promoter Buying
Earthstone Holding (Two) Private Limited acquired 46,958 shares of Chambal Fertilisers & Chemicals Ltd via open market, increasing its stake from 3.699% to 3.710%.
- Promoter stake change
- +0.01%
Chambal Fertilisers & Chemicals Credit Rating
CRISIL re-affirmed Chambal Fertilisers' credit ratings at AA+/Positive (LT) and A1+ (ST) on revised bank loan facilities. No change in rating or outlook.
Chambal Fertilisers & Chemicals Promoter Buying
Earthstone Holding (Two) Pvt Ltd, a promoter group entity, bought 40,000 Chambal Fertilisers shares in the open market. Its stake rose to 3.685% of the company.
- Promoter stake change
- +0.01%
Chambal Fertilisers & Chemicals Promoter Buying
Earthstone Holding (Two) Pvt Ltd bought 5000 Chambal Fertilisers shares in the open market, lifting its stake to 3.670%. The promoter-group increment is marginal and routine.
- Promoter stake change
- +0.00%
Other acquisition announcements
All →Krishna Institute of Medical Sciences Acquisition Worth ₹15 Cr
KIMS acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs.15 Crore via primary infusion. The Sangli hospital reported FY26 turnover of Rs.80.42 Crore.
- Value
- ₹15.00 Cr
Krishna Institute of Medical Sciences Acquisition Worth ₹79.5 Cr
KIMS Ltd acquired a 51% stake in Sarvottam Health Care Private Limited for up to ₹79.50 Crore, aiming to expand its healthcare operations in Kakinada.
- Value
- ₹79.50 Cr
Meesho Acquisition Worth ₹50 Cr
Meesho approved up to Rs.50 Crore further investment in Retail Pulse Labs, payable in tranches. It follows the Kirana Club acquisition, making RPLPL a step-down subsidiary.
- Value
- ₹50.00 Cr
- Execution
- Within 1 year from the closing of the first tranche of the original acquisition
Meesho Acquisition Worth ₹18.74 Cr
Meesho will acquire a further stake in Retail Pulse Labs for ₹18.74 Crore cash. The step-down deal depends on completing the first Kirana Club tranche.
- Value
- ₹18.74 Cr
Meesho Acquisition Worth ₹6.17 Cr
Meesho will acquire 100% of Singapore-based Kirana Club in cash, up to USD 6.5 lakh in tranches. The target runs a digital platform for grocery retailers.
- Value
- ₹6.17 Cr
Skyways Air Services Acquisition Worth ₹3.13 Cr
Skyways Air Services will invest Rs.3.13 Crore in cash for additional equity in UAE subsidiary Skyways SLS Cargo Services LLC. The investment funds working capital needs.
- Value
- ₹3.13 Cr
- Execution
- Indicative completion within 30 days